BlackBarn Capital Partners LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, BlackBarn Capital Partners LP held in its portfolio 16 assets valued at $1,520,651,463 (i.e. $1.52B).

The most valuable assets in the portfolio included: SPDR S&P 500 ETF TR ($1.02B), RESMED INC ($96.35M), and ROIVANT SCIENCES LTD ($66.93M).

The chart below shows the top 10 valuable assets, and the table below shows the top 16 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in BlackBarn Capital Partners LP Portfolio

SPDR S&P 500 ETF TR

RESMED INC

ROIVANT SCIENCES LTD

WARBY PARKER INC

ELANCO ANIMAL HEALTH INC

DIVERSIFIED HEALTHCARE TR

PRIVIA HEALTH GROUP INC

NIQ GLOBAL INTELLIGENCE PLC

NEXTERA ENERGY INC

MCGRAW HILL INC

BlackBarn Capital Partners LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
SPDR S&P 500 ETF TR	1500000	1022880000	TR UNIT
RESMED INC	400000	96348000	COM
ROIVANT SCIENCES LTD	3084300	66929310	SHS
WARBY PARKER INC	3000000	65370000	CL A COM
ELANCO ANIMAL HEALTH INC	1700000	38471000	COM
DIVERSIFIED HEALTHCARE TR	6530140	31671179	COM SH BEN INT
PRIVIA HEALTH GROUP INC	1300000	30823000	COM
NIQ GLOBAL INTELLIGENCE PLC	1800000	29682000	ORDINARY SHARES
NEXTERA ENERGY INC	335000	26893800	COM
MCGRAW HILL INC	1400000	23100000	COM
AMNEAL PHARMACEUTICALS INC	1570000	19782000	COM STK CL A
VIKING THERAPEUTICS INC	550000	19349000	COM
OSCAR HEALTH INC	1300000	18681000	CL A
COGENT COMMUNICATIONS HLDGS	650000	14014000	COM NEW
ARBUTUS BIOPHARMA CORP	1850000	8898500	COM
AXCELIS TECHNOLOGIES INC	96573	7758674	COM NEW